HRES 449 · 104th Congress · Health
Relating to breast implants, the Food and Drug Administration, and breast care.
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Subcommittee on Health and Environment.(1996-06-14)
Plain Language Summary
[AI summary unavailable — showing source text]
Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (20)
8 Democrats12 Republicans